PRIVACY POLICY

COOKIE POLICY

CONTACT

PRESS RELEASES

ADVERTISE

SIGN UP

CONTACT

MEDICAL DEVICE NEWS MAGAZINE

HomeEXECUTIVESConnect Biopharma Expands Executive Leadership Team with Hire of Steven Chan as...

Connect Biopharma Expands Executive Leadership Team with Hire of Steven Chan as CFO

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, today announced the appointment of Mr. Steven Chan as Chief Financial Officer, effective November 22, 2021. Mr. Chan will report to Dr. Zheng Wei, Co-Founder & CEO, and succeed Eric Hall who served as Interim Chief Financial Officer.

“We are delighted to welcome Steven to Connect’s Executive team at this exciting time for the Company. Steven brings over 25 years of financial leadership and expertise across multiple different industry sectors, including healthcare, biotechnology, financial services, consumer products and manufacturing, and in private, private-to-public transition and commercial stage companies that will be of significant benefit to the continued delivery of Connect’s strategic objectives. We would also like to thank Eric for his significant contribution in the past several months as we transitioned into a publicly traded company,” said Dr. Zheng Wei.

Mr. Chan joins Connect from Delphon Industries LLC, a global materials manufacturer for the semiconductor, photonics, electronics and medical industries based in Hayward, California where he served as Chief Financial Officer and led its finance, human resources and legal functions. Prior to Delphon Industries, Mr. Chan served as head of finance and principal financial and accounting officer at Arcus Biosciences, a publicly traded oncology focused biotechnology company where he helped lead its IPO and subsequent public company infrastructure build-out. Mr. Chan has also held financial leadership positions at several listed companies in the technology, financial services, and life sciences sectors, including Myokardia, Inc., Solta Medical Inc., Moody’s Analytics, and Logitech, Inc. He received his B.S. in Business Administration from the Haas School of Business at the University of California, Berkeley and is a Certified Public Accountant in California (inactive).

“I am delighted to be joining Connect to lead their finance function and see great opportunities for the Company’s continued development following their recent IPO and the significant progress achieved with their innovative pipeline,” said Mr. Chan.